| Q1 2024 |
98 |
$423M |
+$27.9M |
-$30.8M |
-$2.89M |
AL, ENSG, CDNA, ISRG, PCRX, EPD |
13F-HR |
5/13/2024, 05:16 PM |
| Q4 2023 |
102 |
$417M |
+$13.6M |
-$28.8M |
-$15.2M |
AL, ENSG, CDNA, ISRG, PCRX, FIVN |
13F-HR |
2/14/2024, 05:15 PM |
| Q3 2023 |
97 |
$399M |
+$7.86M |
-$35.1M |
-$27.3M |
AL, ENSG, ISRG, NVGS, PCRX, PROF |
13F-HR |
11/14/2023, 04:06 PM |
| Q2 2023 |
97 |
$481M |
+$10.6M |
-$22.5M |
-$11.9M |
AL, ENSG, ISRG, PCRX, PROF, NVGS |
13F-HR |
8/8/2023, 05:23 PM |
| Q1 2023 |
112 |
$476M |
+$58.3M |
-$101M |
-$42.7M |
AL, ENSG, NVGS, PCRX, CDNA, EPD |
13F-HR |
4/10/2023, 04:08 PM |
| Q4 2022 |
105 |
$453M |
+$28.8M |
-$142M |
-$113M |
AL, ENSG, PCRX, NVGS, PROF, EPD |
13F-HR |
2/7/2023, 03:42 PM |
| Q3 2022 |
101 |
$455M |
+$30.5M |
-$14.9M |
+$15.6M |
PCRX, AL, ENSG, CDNA, NVGS, EPD |
13F-HR |
11/14/2022, 03:40 PM |
| Q2 2022 |
101 |
$477M |
+$34.9M |
-$7.69M |
+$27.2M |
PCRX, AL, ENSG, NVGS, CDNA, EPD |
13F-HR |
8/1/2022, 04:31 PM |
| Q1 2022 |
103 |
$613M |
+$60.1M |
-$17.4M |
+$42.7M |
PCRX, AL, CDNA, ENSG, NVGS, AOSL |
13F-HR |
5/9/2022, 05:09 PM |
| Q4 2021 |
105 |
$667M |
+$50.1M |
-$27.4M |
+$22.7M |
AL, AOSL, CDNA, PCRX, ENSG, ISRG |
13F-HR |
2/8/2022, 03:06 PM |
| Q3 2021 |
112 |
$673M |
+$83M |
-$28.9M |
+$54.1M |
CDNA, AL, PCRX, ENSG, AOSL, ISRG |
13F-HR |
11/12/2021, 03:43 PM |
| Q2 2021 |
111 |
$704M |
+$65.3M |
-$16.2M |
+$49M |
CDNA, AL, ENSG, AMRC, PCRX, LL |
13F-HR |
7/28/2021, 02:05 PM |
| Q1 2021 |
108 |
$657M |
+$59.6M |
-$43.3M |
+$16.3M |
CDNA, AL, ENSG, PCRX, GFN, AMRC |
13F-HR |
5/14/2021, 05:22 PM |
| Q4 2020 |
99 |
$628M |
+$30.2M |
-$10.5M |
+$19.6M |
CDNA, AL, AMRC, ENSG, LL, PCRX |
13F-HR |
2/12/2021, 03:17 PM |
| Q3 2020 |
99 |
$469M |
+$25.8M |
-$8.05M |
+$17.8M |
CDNA, AL, PCRX, ENSG, AMRC, LL |
13F-HR |
11/12/2020, 03:10 PM |
| Q2 2020 |
90 |
$413M |
+$16.2M |
-$24M |
-$7.78M |
CDNA, AL, PCRX, AMRC, ENSG, FIVN |
13F-HR |
8/13/2020, 04:51 PM |
| Q1 2020 |
96 |
$294M |
+$27M |
-$56.6M |
-$29.6M |
CDNA, AL, ENSG, AMRC, PCRX, GFN |
13F-HR |
5/11/2020, 04:05 PM |
| Q4 2019 |
93 |
$457M |
+$30.2M |
-$14.1M |
+$16.1M |
AL, GFN, CDNA, EVBG, FIVN, ENSG |
13F-HR |
2/14/2020, 03:08 PM |
| Q3 2019 |
95 |
$423M |
+$12.5M |
-$13.7M |
-$1.21M |
AL, CDNA, GFN, ENSG, FIVN, EVBG |
13F-HR |
11/8/2019, 03:10 PM |
| Q2 2019 |
97 |
$464M |
+$37.9M |
-$10.5M |
+$27.4M |
CDNA, AL, ENSG, EVBG, GFN, FIVN |
13F-HR |
8/12/2019, 04:05 PM |
| Q1 2019 |
97 |
$459M |
+$54.1M |
-$15.4M |
+$38.6M |
CDNA, AL, ENSG, EVBG, GFN, FIVN |
13F-HR |
5/13/2019, 04:10 PM |
| Q4 2018 |
93 |
$376M |
+$42.1M |
-$21.8M |
+$20.3M |
CDNA, AL, GFN, ENSG, EVBG, RHT |
13F-HR |
1/18/2019, 03:12 PM |
| Q3 2018 |
101 |
$435M |
+$83.6M |
-$19.4M |
+$64.2M |
CDNA, GFN, AL, ENSG, EVBG, AMBR |
13F-HR |
11/13/2018, 04:21 PM |
| Q2 2018 |
97 |
$347M |
+$56M |
-$11.3M |
+$44.7M |
GFN, CDNA, AL, LL, RHT, NEWR |
13F-HR |
8/9/2018, 04:31 PM |
| Q1 2018 |
95 |
$281M |
+$9.68M |
-$27.9M |
-$18.2M |
AL, RHT, GFN, CDNA, AMRC, AMBR |
13F-HR |
5/9/2018, 05:12 PM |
| Q4 2017 |
91 |
$282M |
+$18.5M |
-$13.8M |
+$4.73M |
AL, GFN, CDNA, RHT, FIVN, SU |
13F-HR |
2/13/2018, 01:51 PM |
| Q3 2017 |
95 |
$269M |
+$28.8M |
-$22.4M |
+$6.37M |
AL, RHT, LL, FIVN, SU, GFN |
RESTATEMENT |
11/14/2017, 04:25 PM |
| Q2 2017 |
89 |
$360M |
+$38.6M |
-$18.3M |
+$20.3M |
RHT, AL, LL, FIVN, AMBR, GFN |
13F-HR |
7/20/2017, 02:55 PM |
| Q1 2017 |
95 |
$231M |
+$4.03M |
-$12M |
-$7.94M |
AL, LL, RHT, ATHN, GFNSL, RTEC |
13F-HR |
5/11/2017, 04:36 PM |
| Q4 2016 |
95 |
$233M |
+$17.6M |
-$11.7M |
+$5.88M |
AL, RTEC, GFNSL, ATHN, AMBR, AOSL |
13F-HR |
2/14/2017, 03:26 PM |
| Q3 2016 |
96 |
$235M |
+$56.3M |
-$18.1M |
+$38.2M |
AL, ATHN, AMBR, RTEC, LL, RHT |
13F-HR |
11/14/2016, 03:31 PM |
| Q2 2016 |
90 |
$214M |
+$38.1M |
-$4.45M |
+$33.6M |
ATHN, EQIX, AL, AMBR, RTEC, RHT |
RESTATEMENT |
8/24/2016, 10:26 AM |
| Q1 2016 |
88 |
$209M |
+$21.8M |
-$14.9M |
+$6.84M |
AL, ATHN, EQIX, RHT, RTEC, GFN |
13F-HR |
5/3/2016, 03:44 PM |
| Q4 2015 |
85 |
$218M |
+$5.26M |
-$10.2M |
-$4.94M |
ATHN, RHT, AL, EQIX, RTEC, CISG |
13F-HR |
2/16/2016, 10:51 AM |
| Q3 2015 |
87 |
$204M |
+$13M |
-$45.2M |
-$32.2M |
RHT, EQIX, AL, ATHN, RTEC, CISG |
13F-HR |
10/16/2015, 11:19 AM |
| Q2 2015 |
88 |
$253M |
+$9.3M |
-$35.2M |
-$25.9M |
AL, RHT, EQIX, PSIX, ATHN, RTEC |
13F-HR |
7/24/2015, 10:49 AM |
| Q1 2015 |
92 |
$301M |
+$22.8M |
-$28.6M |
-$5.83M |
AL, GFN, RHT, PSIX, EQIX, NVDQ |
13F-HR |
5/12/2015, 05:26 PM |
| Q4 2014 |
92 |
$312M |
+$40.8M |
-$11.2M |
+$29.7M |
GFN, EQIX, RHT, CTCT, AL, ATHN |
13F-HR |
2/13/2015, 01:07 PM |
| Q3 2014 |
97 |
$299M |
+$32.7M |
-$22.2M |
+$10.5M |
GFN, EQIXXXXX, AL, ATHN, RHT, CTCT |
13F-HR |
10/15/2014, 04:26 PM |
| Q2 2014 |
99 |
$309M |
+$24.8M |
-$35.4M |
-$10.7M |
GFN, AL, EQIXXXXX, CTCT, ATHN, RHT |
13F-HR |
7/31/2014, 01:25 PM |
| Q1 2014 |
103 |
$337M |
+$47.1M |
-$47.5M |
-$363K |
GFN, AL, ATHN, NVDQ, EQIXXXXX, 2978PS |
13F-HR |
5/6/2014, 04:26 PM |
| Q4 2013 |
97 |
$333M |
|
|
|
NVDQ, GFN, ATHN, AL, CTCT, RHT |
RESTATEMENT |
2/6/2014, 12:38 PM |